BridgeMD
Compares treatment options for Metastatic Adenocarcinoma of the Pancreas
Official title A Study to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety Between Administration of BR2021 and BR2021-1
ClinicalTrials.gov ID: NCT06867497
What this study is testing
What is BR2021?
BR2021 is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for metastatic adenocarcinoma of the pancreas.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this clinical study is to compare and evaluate the pharmacokinetic characteristics and the safety between administration of BR2021 and BR2021-1 in patients with metastatic adenocarcinoma of the pancreas
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 to 74
You may be able to join if
- Those with histologically or cytologically proven metastatic adenocarcinoma of the pancreas
- Those who agree to rule out the possibility of their and their spouses' or sexual partners' pregnancy by using medically recognized methods of...
- Those who spontaneously decide to participate and sign written consent to comply with the subject's precautions after listening to and fully...
You likely can't join if
- In the case of a female subject, pregnant woman or those suspected pregnancy or lactating woman.
- Those who have to administer this study's contraindicated drugs with the investigational product from 2 weeks before the participation until end of...
- Those who can't discontinue a diet (ex. raw grapefruit, grapefruit juice or food containing grapefruit, etc.) that may affect the absorption...
- Those who can't discontinue other drugs except the investigational product of this study that may affect the metabolism and excretion of the drug for...
- Those who have participated in other clinical trials(including bioequivalence tests) and administered their investigational products within 4 weeks...
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years to 74 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.